Advertisement
UK markets open in 4 hours 28 minutes

  • NIKKEI 225

    38,411.47
    -423.63 (-1.09%)
     

  • HANG SENG

    18,547.49
    +68.12 (+0.37%)
     

  • CRUDE OIL

    78.04
    -0.34 (-0.43%)
     

  • GOLD FUTURES

    2,316.50
    -7.70 (-0.33%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • Bitcoin GBP

    50,246.67
    -858.68 (-1.68%)
     

  • CMC Crypto 200

    1,299.52
    -65.61 (-4.81%)
     

  • NASDAQ Composite

    16,332.56
    -16.69 (-0.10%)
     

  • UK FTSE All Share

    4,522.99
    +53.90 (+1.21%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : April 19, 2017

CapitalCube
Updated
Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : April 19, 2017

Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Arena Pharmaceuticals, Inc. a score of 53. Our analysis is based on comparing Arena Pharmaceuticals, Inc. with the following peers – VIVUS, Inc., Orexigen Therapeutics, Inc., Athersys, Inc., Array BioPharma Inc., EnteroMedics Inc., Zafgen, Inc., Albany Molecular Research, Inc. and GlaxoSmithKline plc Sponsored ADR (VVUS-US, OREX-US, ATHX-US, ... Read more (Read more...)

Continue reading